Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reactions
Researchers at Mayo Clinic release new data on adverse drug reactions
February 3rd, 2009
"Over 10 years after their approval as cancer supportive and palliative care agents, erythropoietin and the bisphosphonates began to show unexpected, serious adverse events, which resulted in dramatic changes in how they were subsequently prescribed to cancer patients. The purpose of this opinion piece is to reexamine what happened," scientists in the United States report. "We relied on the published literature as well as the investigators' own experience and preliminary data. The importance of adverse event reporting in cancer supportive and palliative agents should go beyond that which is mandated by the Food and Drug Administration (FDA). Funding agencies and...
Source: Cancer Weekly (2009-02-03)
|
